DelSiTech Ltd will attend LSX Nordics 2026, a leading Nordic life sciences partnering and investment event, taking place on 19–20 May in Copenhagen, Denmark. LSX Nordics provides a focused forum for one-to-one meetings and strategic discussions across the biotech, pharmaceutical, and investment communities.
DelSiTech’s CEO, Laura Chirica, and BD Manager, Milla Runsala, will be available throughout the conference and would be pleased to meet in person.
We also warmly welcome you to DelSiTech’s investment presentation on 19 May at 16:15 in the Iceland Room, where we will share more about the company’s proprietary ultra-long-acting formulation technology and recent progress.
Please feel free to reach out through the partnering platform to schedule a meeting, or connect with us after the presentation.